Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 245
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
MindMed Joins Critical Path Institute’s Patient-Reported Outcome Consortium
Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update
Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
Filament Health Announces Q2 2021 Financial Results
PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of...
In Awe: Psychedelic Assisted Psychotherapy and the Mystical Experience
Myth Busting: Magic Mushroom Spores Have Little to do with Potency
Why Aren’t Psychedelic Drugs Prohibited in the 2021 Tokyo Olympics?
Enzymes Responsible for DMT Synthesis Coexist in Mammalian Brain Cells
More Details on the Psilocybin Mushroom Bluing Reaction
Load more